Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 3 of 3 entries
Sorted by: Best Match Show Resources per page
Correction: Use of extracellular vesicles from lymphatic drainage as surrogate markers of melanoma progression and .

The Journal of experimental medicine

García-Silva S, Benito-Martín A, Sánchez-Redondo S, Hernández-Barranco A, Ximénez-Embún P, Nogués L, Mazariegos MS, Brinkmann K, López AA, Meyer L, Rodríguez C, García-Martín C, Boskovic J, Letón R, Montero C, Robledo M, Santambrogio L, Brady MS, Szumera-Ciećkiewicz A, Kalinowska I, Skog J, Noerholm M, Muñoz J, Ortiz-Romero PL, Ruano Y, Rodríguez-Peralto JL, Rutkowski P, Peinado H.
PMID: 31010898
J Exp Med. 2019 May 06;216(5):1230. doi: 10.1084/jem.2018152204162019c. Epub 2019 Apr 22.

No abstract available.

Cite
García-Silva S, Benito-Martín A, Sánchez-Redondo S, et al. Correction: Use of extracellular vesicles from lymphatic drainage as surrogate markers of melanoma progression and . J Exp Med. 2019;216(5):1230doi: 10.1084/jem.2018152204162019c.
García-Silva, S., Benito-Martín, A., Sánchez-Redondo, S., Hernández-Barranco, A., Ximénez-Embún, P., Nogués, L., Mazariegos, M. S., Brinkmann, K., López, A. A., Meyer, L., Rodríguez, C., García-Martín, C., Boskovic, J., Letón, R., Montero, C., Robledo, M., Santambrogio, L., Brady, M. S., Szumera-Ciećkiewicz, A., Kalinowska, I., Skog, J., Noerholm, M., Muñoz, J., Ortiz-Romero, P. L., Ruano, Y., Rodríguez-Peralto, J. L., Rutkowski, P., & Peinado, H. (2019). Correction: Use of extracellular vesicles from lymphatic drainage as surrogate markers of melanoma progression and . The Journal of experimental medicine, 216(5), 1230. https://doi.org/10.1084/jem.2018152204162019c
García-Silva, Susana, et al. "Correction: Use of extracellular vesicles from lymphatic drainage as surrogate markers of melanoma progression and ." The Journal of experimental medicine vol. 216,5 (2019): 1230. doi: https://doi.org/10.1084/jem.2018152204162019c
García-Silva S, Benito-Martín A, Sánchez-Redondo S, Hernández-Barranco A, Ximénez-Embún P, Nogués L, Mazariegos MS, Brinkmann K, López AA, Meyer L, Rodríguez C, García-Martín C, Boskovic J, Letón R, Montero C, Robledo M, Santambrogio L, Brady MS, Szumera-Ciećkiewicz A, Kalinowska I, Skog J, Noerholm M, Muñoz J, Ortiz-Romero PL, Ruano Y, Rodríguez-Peralto JL, Rutkowski P, Peinado H. Correction: Use of extracellular vesicles from lymphatic drainage as surrogate markers of melanoma progression and . J Exp Med. 2019 May 06;216(5):1230. doi: 10.1084/jem.2018152204162019c. Epub 2019 Apr 22. PMID: 31010898; PMCID: PMC6504212.
Copy Download .nbib Format: NLM
NLRP10 Enhances CD4.

Frontiers in immunology

Vacca M, Böhme J, Zambetti LP, Khameneh HJ, Paleja BS, Laudisi F, Ho AWS, Neo K, Leong KWK, Marzuki M, Lee B, Poidinger M, Santambrogio L, Tsenova L, Zolezzi F, De Libero G, Singhal A, Mortellaro A.
PMID: 29163529
Front Immunol. 2017 Nov 02;8:1462. doi: 10.3389/fimmu.2017.01462. eCollection 2017.

NLRP10 is a nucleotide-binding oligomerization domain-like receptor that functions as an intracellular pattern recognition receptor for microbial products. Here, we generated a

Cite
Vacca M, Böhme J, Zambetti LP, et al. NLRP10 Enhances CD4. Front Immunol. 2017;8:1462doi: 10.3389/fimmu.2017.01462.
Vacca, M., Böhme, J., Zambetti, L. P., Khameneh, H. J., Paleja, B. S., Laudisi, F., Ho, A. W. S., Neo, K., Leong, K. W. K., Marzuki, M., Lee, B., Poidinger, M., Santambrogio, L., Tsenova, L., Zolezzi, F., De Libero, G., Singhal, A., & Mortellaro, A. (2017). NLRP10 Enhances CD4. Frontiers in immunology, 81462. https://doi.org/10.3389/fimmu.2017.01462
Vacca, Maurizio, et al. "NLRP10 Enhances CD4." Frontiers in immunology vol. 8 (2017): 1462. doi: https://doi.org/10.3389/fimmu.2017.01462
Vacca M, Böhme J, Zambetti LP, Khameneh HJ, Paleja BS, Laudisi F, Ho AWS, Neo K, Leong KWK, Marzuki M, Lee B, Poidinger M, Santambrogio L, Tsenova L, Zolezzi F, De Libero G, Singhal A, Mortellaro A. NLRP10 Enhances CD4. Front Immunol. 2017 Nov 02;8:1462. doi: 10.3389/fimmu.2017.01462. eCollection 2017. PMID: 29163529; PMCID: PMC5673625.
Copy Download .nbib Format: NLM
Autoimmune response to transthyretin in juvenile idiopathic arthritis.

JCI insight

Clement CC, Moncrieffe H, Lele A, Janow G, Becerra A, Bauli F, Saad FA, Perino G, Montagna C, Cobelli N, Hardin J, Stern LJ, Ilowite N, Porcelli SA, Santambrogio L.
PMID: 26973882
JCI Insight. 2016 Feb;1(2). doi: 10.1172/jci.insight.85633. Epub 2016 Feb 25.

Juvenile idiopathic arthritis (JIA) is the most common pediatric rheumatological condition. Although it has been proposed that JIA has an autoimmune component, the autoantigens are still unknown. Using biochemical and proteomic approaches, we identified the molecular chaperone transthyretin (TTR)...

Cite
Clement CC, Moncrieffe H, Lele A, et al. Autoimmune response to transthyretin in juvenile idiopathic arthritis. JCI Insight. 2016;1(2)doi: 10.1172/jci.insight.85633.
Clement, C. C., Moncrieffe, H., Lele, A., Janow, G., Becerra, A., Bauli, F., Saad, F. A., Perino, G., Montagna, C., Cobelli, N., Hardin, J., Stern, L. J., Ilowite, N., Porcelli, S. A., & Santambrogio, L. (2016). Autoimmune response to transthyretin in juvenile idiopathic arthritis. JCI insight, 1(2), . https://doi.org/10.1172/jci.insight.85633
Clement, Cristina C, et al. "Autoimmune response to transthyretin in juvenile idiopathic arthritis." JCI insight vol. 1,2 (2016). doi: https://doi.org/10.1172/jci.insight.85633
Clement CC, Moncrieffe H, Lele A, Janow G, Becerra A, Bauli F, Saad FA, Perino G, Montagna C, Cobelli N, Hardin J, Stern LJ, Ilowite N, Porcelli SA, Santambrogio L. Autoimmune response to transthyretin in juvenile idiopathic arthritis. JCI Insight. 2016 Feb;1(2). doi: 10.1172/jci.insight.85633. Epub 2016 Feb 25. PMID: 26973882; PMCID: PMC4784708.
Copy Download .nbib Format: NLM
Showing 1 to 3 of 3 entries